Pharmaceutical Properties
Rituximab is also known as Rituxan (brand name). It is directed against
CD20 antigen as it is a genetically engineered IgG1 monoclonal kappa
antibody. It contains the antibiotic gentamicin and is produced by
mammalian cells in a nutrient medium using suspension culture. It can be
administered intravenously and it appears as a clear colorless sterile,
preservative free liquid concentration available as 100mg/10ml or
500mg/50ml vials. The pH of Rituximab is 7.4 and formulated using sodium
citrate dihydrate, sodium chloride, polysorbate 80 and water for
injecting purposes [29-31].